Human IgE+ B cells are derived from T cell–dependent and T cell–independent pathways

The prevalence of IgE-mediated diseases has been increasing worldwide, yet IgE-expressing B cells are poorly characterized, mainly because of their scarcity and low membrane IgE levels. We sought to study the immunobiology of human IgE-expressing B cells in healthy subjects and patients with allergi...

Full description

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 134; no. 3; pp. 688 - 697.e6
Main Authors Berkowska, Magdalena A., Heeringa, Jorn J., Hajdarbegovic, Enes, van der Burg, Mirjam, Thio, H. Bing, van Hagen, P. Martin, Boon, Louis, Orfao, Alberto, van Dongen, Jacques J.M., van Zelm, Menno C.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.09.2014
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The prevalence of IgE-mediated diseases has been increasing worldwide, yet IgE-expressing B cells are poorly characterized, mainly because of their scarcity and low membrane IgE levels. We sought to study the immunobiology of human IgE-expressing B cells in healthy subjects and patients with allergic disease. We used a stepwise approach for flow cytometric detection and purification of human IgE-expressing B cells in control subjects, CD40 ligand–deficient patients, and patients with atopic dermatitis. Molecular analysis of replication histories, somatic hypermutation (SHM), and immunoglobulin class-switching was performed. Using multicolor flow cytometry, we reliably detected IgE-expressing plasma cells and 2 IgE-expressing memory B-cell subsets. These IgE-expressing cells showed molecular and phenotypic signs of antigen responses. The replication history and SHM levels of IgE+ plasma cells and CD27+IgE+ memory B cells fitted with a germinal center (GC)–dependent pathway, often through an IgG intermediate, as evidenced from Sγ remnants in Sμ-Sε switch regions. CD27−IgE+ cells showed limited proliferation and SHM and were present in CD40 ligand–deficient patients, indicating a GC-independent origin. Patients with atopic dermatitis had normal numbers of blood IgE+ plasma cells and CD27+IgE+ memory B cells but increased numbers of CD27−IgE+ memory B cells with high SHM loads compared with those seen in healthy control subjects and patients with psoriasis. We delineated GC-dependent and GC-independent IgE+ B-cell responses in healthy subjects and indicated involvement of the GC-independent pathway in a human IgE-mediated disease. These findings provide new insights into the pathogenesis of IgE-mediated diseases and might contribute to accurate monitoring of IgE+ B cells in patients with severe disease undergoing anti-IgE treatment.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0091-6749
1097-6825
1097-6825
DOI:10.1016/j.jaci.2014.03.036